Cibus, Inc. CBUS
Agricultural Chemicals · IPO 2017 · data as of November 13, 2026
Cibus, Inc. (CBUS) is a industrial company listed in the US with a market value of about $87M. In the twelve months to September 30, 2026 it had revenue of $5M and net income of -$97M, a net margin of -2131.4%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -31% a year, a 5-year average ROIC of -143%.
About Cibus
Cibus is listed in the US and classified in agricultural chemicals, IPO year 2017. Revenue went from $1M in 2015 to $4M in 2025, growth of about 11.1% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 4874% over three years (dilution for shareholders). It spends 1215% of revenue on research and development.
Score: 0.6 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $4M | $4M | $2M | $157000 | $26M | $24M | $7M | $236000 | $508000 | $399000 |
| Net income | -$97M | -$127M | -$251M | -$268M | -$17M | -$29M | -$45M | -$40M | -$28M | -$26M | -$12M |
| Free cash flow | -$44M | -$51M | -$59M | -$51M | -$21M | -$19M | -$45M | -$35M | -$22M | -$14M | -$20M |
| EPS (diluted) | $-1.48 | $-2.78 | $-10.83 | $-25.95 | $-18.36 | $-39.00 | $-66.00 | $-60.50 | $-45.50 | $-56.00 | $-31.00 |
| Net margin | -2131.4% | -3492.3% | -5898.4% | -14729.1% | -10758.6% | -112.4% | -188.0% | -542.9% | -11820.8% | -5114.2% | -3029.1% |
| ROIC | — | -140.4% | -159.1% | -100.3% | -106.3% | -207.6% | -114.2% | -63.5% | -30.1% | -44.9% | -92.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $12.00, 962% above the current price; targets range from $2.00 to $25.00; the consensus rating is “Buy”; expected EPS is $-0.84 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Cibus pay a dividend?
Not currently.
Is Cibus a good stock to buy?
We do not give buy or sell advice. Cibus scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.